In gastric cancer, the number of tumor‐infiltrating CD8+CD103+ TRM cells is reduced, their cytotoxic function is impaired, and this is negatively correlated with cancer progression and survival. Combining PD‐1 blockade with 4‐1BB costimulation can restore their function. The gene discussed is TNFRSF9; the disease is neoplasm.